MORRIS PLAINS, N.J., May 27, 2008 (PRIME NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced four presentations will be given at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO) held at the McCormick Place Convention Center in Chicago, Illinois, from May 30 - June 3, 2008. The schedule and meeting places for the presentations, together with the abstract numbers are listed below:
